Cardiology

Testosterone treatment may increase risk of venous thromboembolism

Testosterone treatment may increase risk of venous thromboembolism

By

Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.

Managing peripheral artery disease: an updated guideline

Managing peripheral artery disease: an updated guideline

By

The AHA/ACC guideline updates the 2005 recommendations on PAD management.

Statin and PCSK9 inhibitor combination more effective at lowering cholesterol

Statin and PCSK9 inhibitor combination more effective at lowering cholesterol

By

PCSK9 inhibition produces incremental benefits on coronary disease progression in patients treated with statins.

Ambulatory diuretic therapy lowers costs in decompensated heart failure

Ambulatory diuretic therapy lowers costs in decompensated heart failure

Ambulatory high-dose intravenous diuretic therapy could be cost saving compared with hospitalization for intravenous loop diuretic therapy.

Caffeine does not induce arrhythmias in patients with heart disease

Caffeine does not induce arrhythmias in patients with heart disease

By

Caffeine consumption in patients with systolic heart failure does not induce arrhythmias both at rest and during physical exercise.

Folic acid-fortified foods linked to lower risk of congenital heart defects

Folic acid-fortified foods linked to lower risk of congenital heart defects

By

Foods fortified with folic acid are associated with a decrease in infants being born with congenital heart defects.

Increased mortality rates in patients with nocturia

Increased mortality rates in patients with nocturia

By

Patients who experience nocturia, or frequent urination during the night, may have increased mortality rates.

Common medications can cause or worsen heart failure, cautions AHA

Common medications can cause or worsen heart failure, cautions AHA

By

The American Heart Association has published a scientific statement that outlines which medications cause or exacerbate heart failure.

Vagal nerve stimulation does not reduce mortality in heart failure patients

Vagal nerve stimulation does not reduce mortality in heart failure patients

By

At 16 months, 30.3% of patients either died or experienced worsening heart failure.

Patients with atrial fibrillation and stroke risk treated with aspirin over oral anticoagulants

Patients with atrial fibrillation and stroke risk treated with aspirin over oral anticoagulants

By

Specific patient characteristics predicted the type of therapy more likely to be prescribed.

Coronary artery bypass linked to new-onset diabetes

Coronary artery bypass linked to new-onset diabetes

Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.

Smartphone app helps circumvent unnecessary testing for chest pain in ED patients

Smartphone app helps circumvent unnecessary testing for chest pain in ED patients

The HEART pathway app provides doctors in the ED with a digital application an already proven method of assessment.

Non-vitamin K antagonist oral anticoagulants may be safe, effective

Non-vitamin K antagonist oral anticoagulants may be safe, effective

By

Non-vitamin K antagonist oral anticoagulants perform similarly to warfarin for patients with atrial fibrillation.

Alanine aminotransferase serum levels linked to cardiovascular event risk

Alanine aminotransferase serum levels linked to cardiovascular event risk

Incident events were most common in those within the lowest tertile of basline ALT serum.

FDA warns that misuse of antidiarrheal loperamide can cause severe cardiac events

FDA warns that misuse of antidiarrheal loperamide can cause severe cardiac events

By

The FDA warns that the antidiarrheal loperamide can lead to serious cardiac events when taken in high doses.

ART may not reduce HIV-associated arterial inflammation

ART may not reduce HIV-associated arterial inflammation

By

Antiretroviral therapy in HIV-positive patients did not decrease the progression of arterial inflammation.

Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives

Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives

By

Compared with other estrogen doses and progestogen types, low-dose estrogen with levonorgestrel had a decreased risk of adverse events.

Adherence and hypertension in the geriatric patient

Adherence and hypertension in the geriatric patient

Addressing factors that lead to lack of adherence to antihypertensive 
therapy in elderly patients is crucial to improving outcomes.

Survival unimproved with deferred second defibrillation

Survival unimproved with deferred second defibrillation

By

Deferred defibrillation was not associated with improved survival.

Healthy diet reduces hypertension risk after gestational diabetes

Healthy diet reduces hypertension risk after gestational diabetes

By

Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.

Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients

Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients

By

Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.

Patients with psoriasis have an increased risk of abdominal aortic aneurysm

Patients with psoriasis have an increased risk of abdominal aortic aneurysm

Patients with psoriasis are more likely to have an abdominal aortic aneurysm, with the likelihood increasing with more severe psoriasis.

FDA issues warning for 2 diabetes drugs linked to risk of heart failure

FDA issues warning for 2 diabetes drugs linked to risk of heart failure

By

The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.

Coronary bypass surgery reduces mortality for patients with heart failure

Coronary bypass surgery reduces mortality for patients with heart failure

By

Patients with coronary artery disease who were previously not considered candidates for CABG may benefit from the surgery.

Incretin-based medications do not increase heart failure hospitalization

Incretin-based medications do not increase heart failure hospitalization

Regardless of history of heart failure, incretin-based medications are not associated with an increased risk for hospitalization due to heart failure.

Public health initiatives improve out-of-hospital cardiac arrest outcomes

Public health initiatives improve out-of-hospital cardiac arrest outcomes

Training the public in bystander CPR and first responder defibrillation improves outcomes for cardiac arrest that occurs outside of a hospital.

Statins may benefit intermediate-risk patients without CVD

Statins may benefit intermediate-risk patients without CVD

Results from a study presented at ACC in Chicago suggest that statins can be more widely used in patients considered to be intermediate risk for cardiovascular disease.

SSRIs and cardiovascular events—Is there a connection?

SSRIs and cardiovascular events—Is there a connection?

By

A large study found that use of SSRI medications to treat depression does not increase the risk of cardiovascular events in patients 20 to 64 years of age.

E-consultations between PCPs, specialists can increase care access

E-consultations between PCPs, specialists can increase care access

Electronic consultation between PCPs and specialists can resolve cases faster than if a patient followed up with a specialist themselves.

MI risks, symptoms different in women compared with men, per AHA

MI risks, symptoms different in women compared with men, per AHA

By

Women and men experience different symptoms, risks, and outcomes of myocardial infarction.

Sign Up for Free e-newsletters